TY - JOUR
T1 - P2X Receptors
T2 - Potential Therapeutic Targets for Symptoms Associated With Lung Cancer — A Mini Review
AU - Mai, Yonglin
AU - Guo, Zhihua
AU - Yin, Weiqiang
AU - Zhong, Nanshan
AU - Dicpinigaitis, Peter V.
AU - Chen, Ruchong
N1 - Publisher Copyright:
© Copyright © 2021 Mai, Guo, Yin, Zhong, Dicpinigaitis and Chen.
PY - 2021/6/29
Y1 - 2021/6/29
N2 - Symptoms associated with lung cancer mainly consist of cancer-associated pain, cough, fatigue, and dyspnea. However, underlying mechanisms of lung cancer symptom clusters remain unclear. There remains a paucity of effective treatment to ameliorate debilitating symptoms and improve the quality of life of lung cancer survivors. Recently, extracellular ATP and its receptors have attracted increasing attention among researchers in the field of oncology. Extracellular ATP in the tumor microenvironment is associated with tumor cell metabolism, proliferation, and metastasis by driving inflammation and neurotransmission via P2 purinergic signaling. Accordingly, ATP gated P2X receptors expressed on tumor cells, immune cells, and neurons play a vital role in modulating tumor development, invasion, progression, and related symptoms. P2 purinergic signaling is involved in the development of different lung cancer-related symptoms. In this review, we summarize recent findings to illustrate the role of P2X receptors in tumor proliferation, progression, metastasis, and lung cancer- related symptoms, providing an outline of potential anti-neoplastic activity of P2X receptor antagonists. Furthermore, compared with opioids, P2X receptor antagonists appear to be innovative therapeutic interventions for managing cancer symptom clusters with fewer side effects.
AB - Symptoms associated with lung cancer mainly consist of cancer-associated pain, cough, fatigue, and dyspnea. However, underlying mechanisms of lung cancer symptom clusters remain unclear. There remains a paucity of effective treatment to ameliorate debilitating symptoms and improve the quality of life of lung cancer survivors. Recently, extracellular ATP and its receptors have attracted increasing attention among researchers in the field of oncology. Extracellular ATP in the tumor microenvironment is associated with tumor cell metabolism, proliferation, and metastasis by driving inflammation and neurotransmission via P2 purinergic signaling. Accordingly, ATP gated P2X receptors expressed on tumor cells, immune cells, and neurons play a vital role in modulating tumor development, invasion, progression, and related symptoms. P2 purinergic signaling is involved in the development of different lung cancer-related symptoms. In this review, we summarize recent findings to illustrate the role of P2X receptors in tumor proliferation, progression, metastasis, and lung cancer- related symptoms, providing an outline of potential anti-neoplastic activity of P2X receptor antagonists. Furthermore, compared with opioids, P2X receptor antagonists appear to be innovative therapeutic interventions for managing cancer symptom clusters with fewer side effects.
KW - ATP
KW - P2X receptors
KW - antagonist
KW - cancer-related symptoms
KW - tumor microenvironment
UR - http://www.scopus.com/inward/record.url?scp=85110289431&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85110289431&partnerID=8YFLogxK
U2 - 10.3389/fonc.2021.691956
DO - 10.3389/fonc.2021.691956
M3 - Review article
AN - SCOPUS:85110289431
SN - 2234-943X
VL - 11
JO - Frontiers in Oncology
JF - Frontiers in Oncology
M1 - 691956
ER -